Fundraising Foxラクオリア創薬株式会社
1 known investors
Find your way into ラクオリア創薬株式会社
Sign up to see every warm intro you have to ラクオリア創薬株式会社
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ラクオリア創薬株式会社 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RaQualia Pharma is a Nagoya-based drug discovery biotech spun off from Pfizer's former research lab, developing small-molecule drug candidates and out-licensing them to pharmaceutical partners in areas like pain, GI disease, and oncology.
Investors · 1
UTEClisted by UTECTokyo
How we know: UTEC's portfolio page · Not right? Tell us
Frequently asked questions
- What does ラクオリア創薬株式会社 do?
- RaQualia Pharma is a Nagoya-based drug discovery biotech spun off from Pfizer's former research lab, developing small-molecule drug candidates and out-licensing them to pharmaceutical partners in areas like pain, GI disease, and oncology.
- Who are ラクオリア創薬株式会社's investors?
- ラクオリア創薬株式会社's investors include UTEC.